Delivery Order SPE2DB24D2205-SPE2DB25FEHTD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,128.85 to AmerisourceBergen Drug Corp for the supply of Sunosi 150 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Sunosi 150 mg tablets (30-count packaging) valued at $1,013.56. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion master agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $2,445.76 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count). This firm fixed-price contract represents a non-set-aside competitive award and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,141.29 to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Sunosi 150 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is scheduled for ultimate completion on July 9, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on July 17, 2025, for the supply of Sunosi 75 mg tablets (30-count units) with a ceiling value of $4,264.03. This non-set-aside contract represents a firm fixed price delivery order and is part of AmerisourceBergen's broader engagement with DLA's medical supply chain. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 18,...
- The Defense Logistics Agency awarded a $1,881.03 delivery order to AmerisourceBergen Drug Corp for Sunosi 75 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Sunosi 75 mg tablets (30-count packages) valued at $1,344.45. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The contract is scheduled for ultimate completion on September 19, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Sunosi 75 mg tablets (30-count package) with a firm fixed price ceiling value of $3,765.50 and an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside delivery order was placed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,792.60 to AmerisourceBergen Drug Corp for the supply of Sunosi (solriamfetol) 75 mg tablets in a 30-count package. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, and the place of...
- The Defense Logistics Agency awarded a $4,025.37 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count package). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 5, 2025, and performance executed from the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHTDDelivery Order
The Defense Logistics Agency awarded a $2,721.90 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Sunosi 75 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. Sunosi is a wakefulness-promoting medication used to address excessive daytime sleepiness associated with conditions such as narcolepsy and sleep apnea, representing the type of specialized pharmaceutical commodity that the Defense Logistics Agency regularly procures through AmerisourceBergen's established vendor relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/18/25 |